Study author Other target conditions reported | Study type Country Setting | Inclusion criteria |
Index tests (algorithm) Diagnostic approach |
Threshold |
Observer qualifications (number) Experience |
Reference standard Final diagnoses Prevalence (any skin cancer) |
Exclusions Comments (marked *) |
In‐person evaluations | |||||||
Argenziano 2006 | RCT Italy, Spain Primary NR/85 |
Patients asking for screening or exhibiting ≥ 1 skin tumours as seen during routine physical examination (patient‐finding screening). Participating PCPs randomised to either visual inspection alone or visual inspection + dermoscopy; only excised lesions can be included for each arm. |
VI (ABCD) Dermoscopy (3‐point checklist) In‐person (single observer) |
Subjective impression; diagnosis of malignancy | GPs (n = 37) All trained in ABCD rule |
Histology MEL 6 BCC 37; SCC 10 Benign 32 53/85; 62% |
*Only those patients who were considered to have lesions suggestive of skin cancer had histology and could be included; rest had expert diagnosis (making full dataset ineligible for this review) |
Durdu 2011 Invasive melanoma or atypical intraepidermal melanocytic variants |
WPC P‐CS Secondary Turkey 176/200 |
PSL that could not be diagnosed with only dermatologic physical examination; 2x2 included for melanocytic subset | Dermoscopy (ABCD; nonmelanocytic excluded first) (Also evaluated exfoliative cytology) In‐person |
NR | Dermatologist (n = 1; exp NR) Single observer |
Histology MEL: 10; BCC: 34; other malignant 2 SK 24; BN 100; DF 12; warts 16; dirt 1; other 1 10/200; 5% |
‐ |
Soyer 2004 | NC R‐CS Specialist unit Italy 225/231 |
Lesions at pigmented lesion clinic considered by experienced dermatologists to merit excision on clinical grounds | Dermoscopy (no algorithm) In‐person |
NR | Dermatologist (n = 1; exp High)* Single |
Histology MEL: 68; BCC 9 'Benign' 154 77/154; 33% |
*Also reports data for 6 inexperienced observers interpretation of the acquired dermoscopic images; data excluded as includes 3 medical students |
Stanganelli 2000 Invasive melanoma or atypical intraepidermal melanocytic variants |
WPC R‐CS Italy Specialist clinic NR/3372 |
PSL referred by dermatologists and general practitioners either for pre‐surgical assessment or consultation | VI (ABCD)
Dermoscopy (no algorithm) In person (single) |
NR Subjective impression | NR (assumed dermatologist ‐ described as one of the co‐authors; n = 1) | Histology/registry FU MEL 55 BCC 43; benign 3274 98/3372; 3% |
NR |
Image‐based evaluations | |||||||
Carli 2002b Invasive melanoma or atypical intraepidermal melanocytic variants Any |
WPC R‐CS Italy Secondary NR/57 |
Clinically suspicious or equivocal PSL undergoing excision for diagnostic purposes; all ≤ 14 mm diameter | 1. VI (NR)
2. Dermoscopy (NR) Image‐based (blinded) |
NR | Dermatologists (n = 2) High exp ('with experience in the field of '); consensus of 2 |
Histology MM 6, MiS 5 BCC 10 BN 31, SK 1; other 4 11/57; 19% |
4 ‘not evaluables’ excluded (NB these differ between clinical images and dermoscopic images (1 MM excluded from VI analysis) |
Lorentzen 2008 Invasive melanoma |
WPC NR‐CS Specialist clinic Denmark 119/119 |
Patients referred to the specialist naevus clinic; compared classic dermoscopy to acrylic globe magnifier | Dermoscopy (Kenet risk stratification) Image‐based (blinded) |
NR | Dermatologist (n = NR) Average |
Histology MM 24; BCC 13 BN 69; mild/moderate dysplasia 2; SK 9; other 2 24/119; 20% |
1 DF |
Rosendahl 2011 Invasive melanoma or atypical intraepidermal melanocytic variants |
WPC‐algorithms R‐CS Australia Primary 389/463 |
PSL submitted for histology from the primary care skin cancer practice of 1 author | 1. VI (no algorithm) 2. Dermoscopy (pattern; Chaos and Clues) |
1. Subjective impression 2. NR; both characteristics present |
Dermatologist (n = 1) High exp (confirmed by author); single obs |
Histology MM 9; MiS 20 BCC 72; SCC 5 BN 217; BD 18; AK 14*; BNM 140 *considered malignant by study authors 29/463; 6% |
3 poor‐quality images excluded |
Stanganelli 1998a Invasive melanoma or atypical intraepidermal melanocytic variants Any |
WPC R‐CS Italy Training images Italy NR/30 |
PSL images selected from computerised files of the skin cancer clinic | 1. VI (no algorithm)
2. Dermoscopy (no algorithm) Image‐based (clinical image) |
NR; clinical diagnosis | Dermatologists (n = 20) Exp NR (“experience in ELM but (with) no formal training”) Average result |
Histology MEL 10 BCC 4 BN 10, SK 3, other 3 10/30; 33% |
NR BCC results not disaggregated |
Zalaudek 2006 Invasive melanoma or atypical intraepidermal melanocytic variants |
NC R‐CS Specialist clinic Italy NR/165 |
Random sample of excised, equivocal and nonequivocal, PSL and non‐PSLs with melanin or haemoglobin pigmentation in all or part of the lesion | Dermoscopy (3PCL) Image‐based (age, site, gender) |
≥ 2 characteristics present | Mixed (n = 150; exp NR) Average result |
Histology Full sample: MM 18; MiS 11 BCC: 18 79 BN; 26 SK; 8 vascular; 3 DF 26/150; 17% |
15 used for training purposes 5 BCC moved from FP to TN |
3PCL: three‐point checklist; AK: actinic keratosis; alg: algorithm; BD: Bowen’s disease; BCC: basal cell carcinoma; BN: benign naevi; BPC: between person comparison (of tests);CAD: computer‐assisted diagnosis; CCS: case‐control study; CS: case series; cSCC: cutaneous squamous cell carcinoma; DF: dermatofibroma; ELM: epiluminescence microscopy; exp: experience; FP: false positive; FU: follow‐up; LS: lentigo simplex; MiS: melanoma in situ (or lentigo maligna); MM: malignant melanoma; NC: non‐comparative; NR: not reported; Obs: observer; P: prospective; PCP: primary care provider; PLC: pigmented lesion clinic; PSL: pigmented skin lesion; R: retrospective; RCM: reflectance confocal microscopy; SK: seborrhoeic keratosis; SN: Spitz naevi; TN: true negative; VI: visual inspection; WPC: within person comparison (of tests) |